BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38535100)

  • 1. Metabolic Dysfunction Associated Liver Disease in Patients Undergoing Coronary Computed Tomography Angiography.
    Orzan RI; Gligor RI; Agoston R; Cionca C; Zlibut A; Pais R; Seicean A; Agoston-Coldea L
    J Cardiovasc Dev Dis; 2024 Feb; 11(3):. PubMed ID: 38535100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.
    Nishihara T; Miyoshi T; Nakashima M; Miki T; Toda H; Yoshida M; Ichikawa K; Osawa K; Yuasa S
    Cardiovasc Diabetol; 2024 May; 23(1):167. PubMed ID: 38730426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive ability of coronary computed tomography angiography parameters in patients suspected of obstructive coronary artery disease: a single-center cross-sectional study.
    Zlibut A; Orzan RI; Farah D; Cionca C; Muresan ID; Horvat D; Popa ID; Revnic R; Florea M; Mocan T; Agoston-Coldea L
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4074-4085. PubMed ID: 34156686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of epicardial and intrathoracic fat volume does not provide an added prognostic value as an adjunct to coronary artery calcium score and myocardial perfusion single-photon emission computed tomography.
    Possner M; Liga R; Gaisl T; Vontobel J; Clerc OF; Mikulicic F; Benz DC; Gräni C; Stehli J; Fuchs TA; Dey D; Pazhenkottil AP; Herzog BA; Gaemperli O; Buechel RR; Kaufmann PA
    Eur Heart J Cardiovasc Imaging; 2016 Aug; 17(8):885-91. PubMed ID: 26341295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of fractional flow reserve derived from coronary computed tomographic angiography and plaque quantitative analysis in predicting adverse outcomes of non-obstructive coronary heart disease].
    Liu J; Wu Y; Huang H; Wang P; Wu Q; Qiao H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):615-619. PubMed ID: 37366128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Coronary CT Angiography for Predicting Poor Cardiac Outcome in Stroke Patients without Known Cardiac Disease or Chest Pain: The Assessment of Coronary Artery Disease in Stroke Patients Study.
    Yoon SH; Kim E; Jeon Y; Yi SY; Bae HJ; Jang IK; Lee JM; Yoo SM; White CS; Chun EJ
    Korean J Radiol; 2020 Sep; 21(9):1055-1064. PubMed ID: 32691541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved long-term prognostic value of coronary CT angiography-derived plaque measures and clinical parameters on adverse cardiac outcome using machine learning.
    Tesche C; Bauer MJ; Baquet M; Hedels B; Straube F; Hartl S; Gray HN; Jochheim D; Aschauer T; Rogowski S; Schoepf UJ; Massberg S; Hoffmann E; Ebersberger U
    Eur Radiol; 2021 Jan; 31(1):486-493. PubMed ID: 32725337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of epicardial adipose tissue volume in combination with coronary plaque and flow assessment for the prediction of major adverse cardiac events.
    Brandt V; Bekeredjian R; Schoepf UJ; Varga-Szemes A; Emrich T; Aquino GJ; Decker J; Bayer RR; Ellis L; Ebersberger U; Tesche C
    Eur J Radiol; 2022 Mar; 148():110157. PubMed ID: 35063819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals.
    Han D; Hartaigh BÓ; Gransar H; Lee JH; Rizvi A; Baskaran L; Schulman-Marcus J; Dunning A; Achenbach S; Al-Mallah MH; Berman DS; Budoff MJ; Cademartiri F; Maffei E; Callister TQ; Chinnaiyan K; Chow BJW; DeLago A; Hadamitzky M; Hausleiter J; Kaufmann PA; Raff G; Shaw LJ; Villines TC; Kim YJ; Leipsic J; Feuchtner G; Cury RC; Pontone G; Andreini D; Marques H; Rubinshtein R; Hindoyan N; Jones EC; Gomez M; Lin FY; Chang HJ; Min JK
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):675-683. PubMed ID: 28977374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting major adverse cardiac events based on multi-parameter coronary computed tomography angiography.
    Wang J; Zhou L; Chen H; Zeng S; Wu Q; Fang X
    Med Phys; 2022 Jun; 49(6):3612-3623. PubMed ID: 35320875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial fat volume, an independent risk factor for major adverse cardiovascular events, had an incremental prognostic value to myocardial perfusion imaging in Chinese populations with suspected or known coronary artery disease with a normal left ventricular ejection fraction.
    Yang L; Yu W; Wan P; Wang J; Shao X; Zhang F; Yang X; Chen Y; Li Q; Jiang D; Wang Y; Jiang Q; Wang J; Wang Y
    Front Cardiovasc Med; 2023; 10():1261215. PubMed ID: 37849937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals.
    Min JK; Labounty TM; Gomez MJ; Achenbach S; Al-Mallah M; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng V; Chinnaiyan KM; Chow B; Cury R; Delago A; Dunning A; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann P; Kim YJ; Leipsic J; Lin FY; Maffei E; Raff G; Shaw LJ; Villines TC; Berman DS
    Atherosclerosis; 2014 Feb; 232(2):298-304. PubMed ID: 24468142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-Based Leiden Score Outperforms Confirm Score in Predicting Major Adverse Cardiovascular Events for Diabetic Patients with Suspected Coronary Artery Disease.
    Liu Z; Ding Y; Dou G; Wang X; Shan D; He B; Jing J; Chen Y; Yang J
    Korean J Radiol; 2022 Oct; 23(10):939-948. PubMed ID: 36098342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated stetatotic liver disease patients: A meta-analysis.
    De Filippo O; Di Pietro G; Nebiolo M; Ribaldone DG; Gatti M; Bruno F; Gallone G; Armandi A; Birtolo LI; Zullino V; Mennini G; Corradini SG; Mancone M; Bugianesi E; Iannaccone M; De Ferrari GM; D'Ascenzo F
    Eur J Clin Invest; 2024 Feb; ():e14188. PubMed ID: 38396359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Aortic Plaque Burden and Prediction of Cardiovascular Events in Patients Undergoing 320-row Multidetector CT Coronary Angiography.
    Otsuka K; Ishikawa H; Yamaura H; Hojo K; Kono Y; Shimada K; Kasayuki N; Fukuda D
    J Atheroscler Thromb; 2024 Mar; 31(3):273-287. PubMed ID: 37704429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of intrathoracic fat adds prognostic value in women undergoing myocardial perfusion imaging.
    Haider A; Possner M; Messerli M; Bengs S; Osto E; Maredziak M; Portmann A; Fiechter M; Giannopoulos AA; Treyer V; Gaisl T; von Felten E; Patriki D; Benz DC; Fuchs TA; Gräni C; Pazhenkottil AP; Buechel RR; Kaufmann PA; Gebhard C
    Int J Cardiol; 2019 Oct; 292():258-264. PubMed ID: 31178224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality.
    Tamaki N; Kimura T; Wakabayashi SI; Umemura T; Kurosaki M; Loomba R; Izumi N
    Aliment Pharmacol Ther; 2024 Jul; 60(1):61-69. PubMed ID: 38664876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial coronary CT angiography-derived fractional flow reserve and plaque progression can predict long-term outcomes of coronary artery disease.
    Yang L; Xu PP; Schoepf UJ; Tesche C; Pillai B; Savage RH; Tang CX; Zhou F; Wei HD; Luo ZQ; Wang QG; Zhou CS; Lu MJ; Lu GM; Zhang LJ
    Eur Radiol; 2021 Sep; 31(9):7110-7120. PubMed ID: 33630163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease.
    Tamaki N; Wakabayashi SI; Kimura T; Yasui Y; Tsuchiya K; Nakanishi H; Huang DQ; Umemura T; Kurosaki M; Izumi N
    Hepatol Res; 2024 Feb; ():. PubMed ID: 38400797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.